Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Power Life Sciences Inc.500 enrolled

Overview

Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

ALS Amyotrophic Lateral Sclerosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Lives in the United States * Is 18+ years old * Participant has a diagnosis of Amyotrophic Lateral Sclerosis (ALS) * Participant has enrolled in an interventional clinical for ALS (self-reported) Exclusion Criteria * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form * No diagnosis of Amyotrophic Lateral Sclerosis (ALS) confirmed

Outcomes

Primary Outcomes

Number of patient decides to enroll in clinical trial